Publications 2023
Caloric restriction for the immunometabolic control of human health.
Procaccini C, de Candia P, Russo C, De Rosa G, Lepore MT, Colamatteo A, Matarese G.
Cardiovasc Res. 2023 Feb 27:cvad035. doi: 10.1093/cvr/cvad035.
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis.
Bruno A, Dolcetti E, Azzolini F, Buttari F, Gilio L, Iezzi E, Galifi G, Borrelli A, Furlan R, Finardi A, Carbone F, De Vito F, Musella A, Guadalupi L, Mandolesi G, Matarese G, Centonze D, Stampanoni Bassi M.
Mult Scler Relat Disord. 2023 Jan 24;71:104528. doi: 10.1016/j.msard.2023.104528.
Osteopontin Is Associated with Multiple Sclerosis Relapses
Stampanoni Bassi M, Buttari F, Gilio L, Iezzi E, Galifi G, Carbone F, Micillo T, Dolcetti E, Azzolini F, Bruno A, Borrelli A, Mandolesi G, Rovella V, Storto M, Finardi A, Furlan R, Centonze D, Matarese G.
Biomedicines. 2023 Jan 11;11(1):178. doi: 10.3390/biomedicines11010178.
Pre-vaccination glucose time in range correlates with antibody response to SARS-CoV-2 vaccine in type 1 diabetes.
Alhamar G, Briganti S, Maggi D, Viola V, Faraj M, Zannella C, Galdiero M, Franci G, Fusco C, Isgrò C, Leanza G, Malandrucco I, Spinelli A, Tramontana F, Iaria D, Tortoriello R, Pieralice S, Rosati M, Matarese G, Pozzilli P, Galgani M, Strollo R.
J Clin Endocrinol Metab. 2023 Jan 6:dgad001. doi: 10.1210/clinem/dgad001.
